Skip to main content

and
  1. No Access

    Article

    Urinary metabolites of amitriptylinoxide and amitriptyline in single-dose experiments and during continuous therapy

    In a cross-over design, six healthy volunteers received 50 mg amitriptylinoxide (AT-NO) IV and orally and 50 mg amitriptyline (AT) IV. Urine was collected completely for 8 h and occasionally up to 48 h. In add...

    B. Becher, W. Fischer, Z. Taneri, E. Scholz, W. E. Müller in Psychopharmacology (1992)

  2. No Access

    Article

    Therapeutic concentrations of lithium and carbamazepine inhibit cGMP accumulation in human lymphocytes

    Although a large variety of biochemical effects have been reported for lithium (Li) and carbamazepine (Cbm), the final molecular mechanism underlying their therapeutic efficacy for recurrent affective disorder...

    T. Schubert, L. Stoll, W. E. Müller in Psychopharmacology (1991)

  3. No Access

    Article

    Piracetam elevates muscarinic cholinergic receptor density in the frontal cortex of aged but not of young mice

    Chronic treatment (2 weeks) with piracetam (500 mg/kg, once daily PO) elevatedm-cholinoceptor density in the frontal cortex of aged (18 months) female mice by about 30–40%, but had no effect onm-cholinoceptor den...

    H. Pilch, W. E. Müller in Psychopharmacology (1988)